QuicKey Pro Human ICAM-1/CD54(intercellular adhesion molecule 1) ELISA Kit
中文名称：QuicKey Pro-人细胞间粘附分子1(ICAM-1/CD54)酶联免疫吸附测定试剂盒
Price:
- 反应性： Human
- 检测范围： 0.25-16 ng/mL
- 灵敏度： 0.15 ng/mL
| 系列介绍 | 与传统ELISA试剂盒相比，将实验时间缩短了至少1-2小时，同时提高了试剂盒的灵敏度，让客户可以获得更加精确的实验结果。该系列是Elabscience自主开发的新技术，旨在帮助客户以更为高效的方式进行科学研究。 |
| 用途 | 试剂盒用于体外定量检测人血清、血浆或其他生物体液中ICAM-1浓度 |
| 产品应用 | ELISA |
| 检测原理 | 本试剂盒采用双抗体夹心ELISA法。用抗人ICAM-1抗体包被于酶标板上，实验时加入样品（或标准品）和辣根过氧化物酶标记的抗人ICAM-1检测抗体，样本（或标准品中）的人ICAM-1会与包被抗体及辣根过氧化物酶标记的抗人ICAM-1抗体结合，形成双抗体夹心的免疫复合物，游离的成分被洗去。加入显色底物(TMB)，TMB在辣根过氧化物酶的催化下呈现蓝色，加终止液后变成黄色。用酶标仪在450 nm波长处测OD值，ICAM-1浓度与OD450值之间呈正比，通过绘制标准曲线计算出样品中ICAM-1的浓度。 |
| 反应类型 | Sandwich-ELISA |
| 规格 |
96 T
/ 48 T
/ 96 T × 5
|
| 反应时间 | 1 h 30 min |
| 反应性 | Human |
| 检测方法 | 比色法;ELISA;夹心法 |
| 检测范围 | 0.25-16 ng/mL |
| 灵敏度 | 0.15 ng/mL |
| 样本体积 | 50 μL |
| 样本类型 | 血清、血浆或其他生物体液 |
| 特异性 | 可检测样本中的人ICAM-1，且与其它类似物无明显交叉反应 |
| 精密度 | 板内，板间变异系数均<10% |
| 回收率 | 80%-120% |
| 储存条件 | 2-8℃ |
| 有效期 | 6个月 |
| 数据处理 |
-
Super-enhancer-driven LIF promotes the mesenchymal transition in glioblastoma by activating ITGB2 signaling feedback in microglia
IF: 15.900 -
One-Year Outcomes for Depression and Anxiety in SLE Patients
IF: 4.700 -
Aberrant innate immune profile associated with COVID-19 mortality in Pretoria, South Africa
IF: 4.500Journal： CLINICAL IMMUNOLOGY (2024)Reactivity：HumanSample Type：plasma -
Pathogenesis and Biomarkers of Cancer-Related Ischemic Stroke
IF: 4.200Journal： Journal of Inflammation Research (2024)Reactivity：HumanSample Type：Peripheral venous blood -
EFFECT OF HEMODIALYSIS WITH MEDIUM CUT-OFF vs. HIGH-FLUX MEMBRANES ON ENDOTHELIAL FUNCTION OF PATIENTS WITH CHRONIC KIDNEY DISEASE
IF: 3.000 -
The effect of eight weeks combined training with omega-3 supplementation on the levels of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in older women
IF: 3.000 -
Early Use of PCSK9 Inhibitors in the Prognosis of Patients with Acute Coronary Syndrome by Protecting Vascular Endothelial Function
IF: 2.900 -
Effect of medium cut-off and high-flux hemodialysis membranes on blood pressure assessed by ambulatory blood pressure monitoring
IF: 2.400 -
Sex Differences and Cytokine Profiles among Patients Hospitalized for COVID-19 and during Their Recovery: The Predominance of Adhesion Molecules in Females and Oxidative Stress in Males
IF: 7.800 -
Comparison of platelet-and endothelial-associated biomarkers of disease activity in people hospitalized with Covid-19 with and without HIV co-infection
IF: 7.300
